Feasibility of using real world evidence to inform decisions on conducting a cost effectiveness analysis- an example of stroke risk reduction therapies in atrial fibrillation
Authors:
Saunders O, Akehurst R, Zhong Y, Amorosi S, Gavaghan M, Hemstock M, Wong T and Panikker S.
Publication type:
Conference Proceedings – Poster
Publication Name:
ISPOR Europe 2019
Citation:
Saunders O, Akehurst R, Zhong Y, Amorosi S, Gavaghan M, Hemstock M, Wong T and Panikker S. Feasibility of using real world evidence to inform decisions on conducting a cost effectiveness analysis- an example of stroke risk reduction therapies in atrial fibrillation. 19th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Copenhagen, Denmark. 2-6 November 2019. PCV114.
